I want to thank all the witnesses for being here and for their testimony.
I also want to put on the record that we're dealing with Bill C-368 here. It deals with Vanessa's Law, which does not deal with the issue of cost recovery or labelling. I think the 20% number of businesses leaving was in relation to cost recovery and labelling.
Let me start with Dr. Moore Hepburn.
Thank you for your testimony. You said that you have serious concerns if this bill passes. You said it would undermine “provider trust and consumer trust”. I think that was your testimony.
In a brief that was submitted to the committee by the Canadian Medical Association, they took the position that “decisions regarding health care products, including NHPs, should be based on sound scientific evidence.” Do you agree with their evidence?